The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring. 
 
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence. 

Related News Articles

Headline
A joint advisory issued the week of July 8 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI and several international…
Headline
The AHA July 2 submitted comments to the Cybersecurity and Infrastructure Security Agency on its proposed rule establishing reporting requirements for…
Headline
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center June 27 issued an alert about a critical vulnerability in MOVEit, a…
Headline
A joint report released June 26 by the Cybersecurity and Infrastructure Security Agency, FBI, the Australian Cyber Security Centre and Canadian Centre for…
Headline
The Health Information Sharing and Analysis Center June 27 issued a threat bulletin alerting the health sector to active cyberthreats exploiting TeamViewer. H-…
Headline
The FBI and Department of Health and Human Services June 24 released an advisory about cyberthreat actors targeting health care organizations in attempts to…